Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Try us for 14 days
Try a trial subscription for access to our quality journalism
Diagnostics company launches first blood test, doubles workforce and eyes profit
Blusense Diagnostics, a spin-out from the Technical University of Denmark (DTU), has launched its first product - a blood test to diagnose Dengue. The company expects to yield profit around 2022 and employ at least 70 people already next year.
